Hold at ≤3% with refined 1 ATR stop, pre-committed alpha-loss trigger, and Q3 earnings decision tree — neither passive Hold nor preemptive Underweight
Hold MDLZ at ≤3% of portfolio with no adds pre-Q3. The aggressive analyst is correct on directional bias but wrong on timing and sizing; the conservative analyst is correct on catalyst risk but wrong on stop placement ($57.35 = 0.35 ATR, guaranteeing whipsaw). The neutral analyst correctly threads the needle: $56.50 stop (1 ATR) gives position room to breathe through normal volatility while defending the structural thesis. The 200 SMA has defended for 42+ sessions, franchise quality is intact, dividend is safe, and 0.40 beta provides portfolio ballast — but the chart is broken enough to argue against adding, and the Q3 catalyst is binary enough to argue against preemptive trimming. Apply binding 9/24 and 9/28 lessons: pre-committed alpha-loss trigger (automatic 5% trim if MDLZ underperforms SPY by -1.0% over any 5-session rolling window, tested intra-week) and trim magnitude calibrated to 90% lower bound.
| Position | Action |
|---|---|
| Default (pre-Q3) | Maintain current exposure at ≤3% of portfolio; do not add pre-Q3 |
| Bullish re-engagement: close >$58.54 (200 SMA) on volume ≥7M with MACD histogram turning positive AND RSI reclaiming 40 | Add 0.5% of portfolio with stop at $57.35, upgrade to Overweight |
| Bear confirmation: close <$57.35 on volume ≥10M | Trim to 90% of benchmark weight with downside target $54-56 |
| Gross margin ≥31% with raised FY26 guidance | Upgrade to Overweight, scale to 4.5% with stop at $58.00 |
| Gross margin 29-31% with maintained guidance | Maintain Hold, no action |
| Gross margin <29% OR cut to FY26 EPS guidance | Trim to Underweight at 85% of benchmark weight |
| Buyback resumption announcement | Upgrade to Overweight (materially weakens bear case) |
| Capitulation: pullback to $53.40-$54.00 zone with RSI divergence and capitulation volume | Defensive add with stop at $51.00 |
| Net debt/EBITDA in next 10-Q prints >3.5x | Force Hold-to-Underweight review independent of price action |
The "breakdown" is actually a technical rejection of the 200 SMA with momentum indicators at oversold extremes, setting up a coiled-spring reversal into a Q3 catalyst, while the cocoa-driven margin compression is normalizing and consensus is underpricing a 23% forward earnings recovery at a 17.3x PE with a 6.8% total shareholder yield as a floor.
| Indicator | Value | Signal |
|---|---|---|
| 200 SMA | $58.54 | bearish |
| 50 SMA | $61.44 | bearish |
| 10 EMA | $59.38 | bearish |
| RSI(14) | 30.27 | bullish |
| Bollinger Upper Band | $63.12 | neutral |
| Bollinger Middle Band (20 SMA) | $60.53 | neutral |
| Bollinger Lower Band | $57.94 | neutral |
| MACD Line | -0.85 | bearish |
| MACD Signal | -0.51 | bearish |
| MACD Histogram | -0.35 | neutral |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: MDLZ underperforms SPY by -1.0% over any 5-session rolling window
Then: AUTOMATICALLY trim 5% into strength; tested intra-week, not on 5-session closes
EV: +6.4% to $61.44 initial target; +9.3% to $63.12 extended target (BOLL upper / prior swing high) · concedes: The bear correctly identifies that 2025 gross margin collapsed to 28.4% from 39.1% in 2024 and that operating income fell to $3.62B from $6.67B; The stock did close below the 200 SMA on October 1st; The bear is correct to flag that 2025 represents a significant earnings trough
MDLZ is in a confirmed technical downtrend with a debt-funded shareholder yield, structurally impaired cocoa costs, and an asymmetric Q3 catalyst where downside risk materially exceeds upside—warranting a HOLD rating until a close below $57.35 triggers a SELL.
· concedes: Cocoa prices have declined materially from the $10K+ peak (though not to historical norms); Revenue did grow 5.7% in 2025 even while gross margin was collapsing — some pricing power exists; RSI at 30.27 is technically oversold and at historical washout levels; If MDLZ closes back above $58.55 on volume, the bull's setup is confirmed and the thesis requires re-evaluation; A close below $57.35 would trigger the SELL signal with targets at $54-55
→ vs conservative: The 4-7% downside vs. 6% upside asymmetric risk-reward assumes normal earnings environment, but cocoa normalization is already priced into $3.36 forward estimates and easy comps make the upside bar lower than the downside bar
→ vs conservative: Calling 9.9% drawdown in 11 sessions 'institutional distribution' without 13F data, block trade prints, or insider sales is predetermined bearish narrative; mechanical ex-dividend flow (0.52 dividend on Sept 30) accounts for apparent decline
→ vs conservative: GLP-1 'unpriced risk' framing ignores the 5-10 year structural horizon being used to justify missing a 2-quarter tactical recovery
→ vs neutral: 'Quiet news flow' framed as inconclusive is actually confirmation—no panic, no scandal, no structural break in a $74B cap consumer staples giant approaching a catalyst is bullish absence of forced sellers
→ vs conservative: Macro ignored entirely: rate hike expectations fading, soft jobs report, easing yields, 8% recession odds (defensive staples outperform), 80% Iran ceasefire probability de-escalating commodity input tail risk
| ATR(14) |
| $1.17 |
| neutral |
| Close | $57.76 | neutral |
Support: 57.35 · 55 · 56 | Resistance: 58.54 · 59.38 · 60.53 · 61.44 · 63.12
MDLZ has traced a clear topping-and-breakdown sequence, falling roughly 10.0% from the late-August peak of $64.13 (2026-08-24) to $57.76 by 2026-10-01, with the 200 SMA at $58.54 emerging as the critical long-term trend line (price $0.78 below, intraday pierced $1.19 below). The technical posture presents a mean-reversion/bottoming cluster: RSI at 30.27 (second consecutive sub-30 print), MACD histogram narrowing to -0.35 despite bearish signal alignment, Bollinger bandwidth compressed from ~$7.64 in August to ~$5.18 in October, and ATR compressed to $1.17 (~34% from early August peak of $1.78), all suggesting an imminent directional breakout typically within 5–15 sessions. The bias is defensive rather than directional: a close above $58.54 signals bullish relief toward $60.53–$63.12, while a close below $57.35 confirms the 200 SMA breakdown and opens $55–$56 as next target.
Market Cap
$74.27B
PE (TTM)
21.3x
Forward PE
17.3x
PEG Ratio
0.86
Price/Book
2.80x
EPS (TTM)
$2.73
Forward EPS
$3.36
Dividend Yield
3.6%
Beta
0.40
52-Week Range
$51.20 – $66.65
50-Day MA
$61.96
200-Day MA
$59.58
Book Value/Share
$20.80
Total Revenue (2025)
$38,537M
Gross Profit (2025)
$10,935M
Gross Margin (2025)
28.4%
Operating Income (2025)
$3,620M
Operating Margin (2025)
9.4%
Net Income (2025)
$2,451M
Diluted EPS (2025)
$1.89
EBITDA (2025)
$4,971M
Operating Cash Flow (2025)
$4,514M
Capital Expenditure (2025)
($1,279M)
Free Cash Flow (2025)
$3,235M
Free Cash Flow (TTM)
~$3,390M
FCF/Revenue
~5.7%
Dividends Paid (2025)
($2,487M)
Buybacks (2025)
($2,385M)
Total Debt
$21,622M
Net Debt
$19,500M
Net Debt/EBITDA
~3.2x
Debt/Equity
82.6%
Current Ratio
0.60
Goodwill
$24,226M
Other Intangibles
$19,533M
Total Assets
$71,122M
Stockholders' Equity
$25,750M
Return on Equity (TTM)
13.3%
Return on Assets (TTM)
4.1%
Net Margin
8.9%
Total Shareholder Yield
~6.8%
Strengths
Concerns
HOLD with bullish bias for new money on any pullback toward $61.96 (50-day MA) or $59.58 (200-day MA). MDLZ is a high-quality defensive compounder facing a temporary earnings compression from peak cocoa input costs, with gross margins collapsed to 28.4% in 2025 vs. 39.1% in 2024, but the underlying FCF base ($3.2B+ annually), 3.6% dividend yield, and 6.8% total shareholder yield remain intact. The forward EPS consensus of $3.36 (+23% from TTM $2.73) implies meaningful earnings recovery as commodity costs normalize toward historical levels, with a reasonable 17.3x forward PE and sub-1.0 PEG (0.86) suggesting growth is underappreciated. Primary risk is chasing near 52-week highs; buy-on-dip strategy preferred for new positions.
Macro: Fed rate-hike expectations fading (96% probability of NO cuts in 2026 per Polymarket); September jobs report missed; Treasury yields easing post-jobs miss; geopolitical inflation shock from Iran war is in rearview mirror but pass-through persists in CPI prints; US recession odds at 8% by year-end 2026 (-2pp week); ceasefire holds 80% through Oct 31 and 62% through year-end.